Health: Spain's 4th Least Inflationary Group

10 September 1995

Prices of medicines and other health care products have fallen significantly over the last four years in Spain, reports the Spanish daily newspaper Cinco Dias.

The reduction in prices of pharmaceutical products proposed by the Spanish government and supported by the pharmaceutical industry in Spain, and the growing competition between health care insurers - formerly the protagonists behind the inflationary effect in the health sector - now means that it is one of the four least inflationary sectors in Spain within the country's consumer price index.

The prices of medicines and therapeutic products, medical services provided in and outside hospitals and medical insurance have changed substantially in recent years. In December 1991, the health and medicines group had an inflation rate of 10.4%; by the end of 1994, this had fallen to 3.7%, reports Cinco Dias.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight